The FDA has recalled batches of birth control pills because they may be less effective.


Tydemy's maker is recalling two batches due to diminished efficacy.

Lupin, a New Jersey manufacturer, recalled the batches on Saturday after tests found low levels of ascorbic acid, an inactive ingredient, and high levels of a "known impurity."

"This could potentially impact the product's effectiveness which could potentially result in unexpected pregnancy," the manufacturer added.

On Tuesday, the FDA warned that Tydemy tablets' insufficient vitamin C content may diminish their pregnancy-prevention efficacy.

Lupin and the FDA reported "no reports of adverse events" from pill use.The impacted batches were dispersed between June 3 and May 31, 2022, and expire in January or September 2024.

Lupin's news announcement encourages Tydemy users to keep taking it for now and "immediately contact their pharmacist, physician, or medical provider for advice regarding an alternative treatment."

The corporation didn't respond to a request for more information about the pill's impurity and ascorbic acid.Packaging lot numbers identify recalled batches: One batch, a pack of 28 tablets, has lot number L200183, while the other, three packs of 28 pills, has lot number L201560.

Lupin's notice advises patients to report side effects to their doctor and the FDA's MedWatch Adverse Event Reporting program.Pharmacists and dealers are advised to "discontinue distribution of the recalled product lots immediately."

"Eras Tour Truckers Receive $100K Bonuses"

Thanks for watching  Interesting News